Fusarium infections are very rare in HIV-infected patients, even in patients in advanced stages of immunosuppression. All the reported cases in the literature are of disseminated infection, and with poor outcomes despite prompt and appropriate treatment. To the best of our knowledge, this is the first report of a localized infection with Fusarium keratoplasticum in an HIV-positive patient, successfully treated with a combination of antifungal therapy and surgical removal of the focus.
EsnakulaAKSummersINaabTJ.Fatal disseminated fusarium infection in a human immunodeficiency virus positive patient. Case Rep Infect Dis2013;
2013: 379320.
2.
NucciFNouérSACaponeDet al.
Fusariosis. Semin Respir Crit Care Med2015;
36: 706–714.
3.
NucciMAnaissieE.Fusarium infections in immunocompromised patients. Clin Microbiol Rev2007;
20: 695–704.
4.
CampoMLewisREKontoyiannisDP.Invasive fusariosis in patients with hematologic malignancies at a cancer center: 1998-2009. J Infect2010;
60: 331–337.
5.
ParkBJPappasPGWannemuehlerKAet al.
Invasive non-Aspergillus mold infections in transplant recipients, United States, 2001–2006. Emerging Infect Dis2011;
17: 1855–1864.
6.
MansooryDRoozbahanyNAMazinanyHet al.
Chronic Fusarium infection in an adult patient with undiagnosed chronic granulomatous disease. Clin Infect Dis2003;
37: e107–e108.
7.
EljaschewitschJSandfortJTintelnotKet al.
Port-a-cath-related Fusarium oxysporum infection in an HIV-infected patient: treatment with liposomal amphotericin B. Mycoses1996;
39: 115–119.
8.
GuarroJNucciMAkitiTet al.
Mixed infection caused by two species of Fusarium in a human immunodeficiency virus-positive patient. J Clin Microbiol2000;
38: 3460–3462.
AnaissieEPaetznickVProffittRet al.
Comparison of the in vitro antifungal activity of free and liposome-encapsulated amphotericin B. Eur J Clin Microbiol Infect Dis1991;
10: 665–668.
11.
BoutatiEIAnaissieEJ.Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years’ experience at a cancer center and implications for management. Blood1997;
90: 999–1008.
12.
CórdobaSRoderoLVivotWet al.
In vitro interactions of antifungal agents against clinical isolates of Fusarium spp. Int J Antimicrob Agents2008;
31: 171–174.
13.
McCarthyMWPetraitisVWalshTJ.Combination therapy for the treatment of pulmonary mold infections. Expert Rev Respir Med2017;
11: 481–489.
14.
PerfectJRMarrKAWalshTJet al.
Voriconazole treatment for less‐common, emerging, or refractory fungal infections. Clin Infect Dis2003;
36: 1122–1131.
